国际流行病学传染病学杂志
國際流行病學傳染病學雜誌
국제류행병학전염병학잡지
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY AND INFECTIOUS DISEASE
2011年
4期
243-245
,共3页
脂肪肝%双环醇%多烯磷脂酰胆碱%熊去氧胆酸
脂肪肝%雙環醇%多烯燐脂酰膽堿%熊去氧膽痠
지방간%쌍배순%다희린지선담감%웅거양담산
Fatty liver%Bicyclol%Polyene phosphatidylcholine%Ursodeoxycholic acid
观察双环醇联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝炎的疗效。方法将80例非酒精性脂肪性肝炎患者,按数字表法随机分为治疗组(40例)及对照组(40例)。治疗组在控制饮食、适当运动基础上给予双环醇联合多烯磷脂酰胆碱治疗;对照组在控制饮食、适当运动基础上给予熊去氧胆酸治疗。全部病例均连续治疗12周。结果治疗组总有效率为85.0%(34/40),对照组为55.0%(22/40),两组差异有统计学意义(x2=8.5,P<0.01)。治疗后,治疗组ALT、AST、TG、TC与对照组相比,差异有统计学意义(t=2.13、3.36、5.00、4.45,P<0.05)。结论应用双环醇联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝炎有效,值得临床应用。
觀察雙環醇聯閤多烯燐脂酰膽堿治療非酒精性脂肪性肝炎的療效。方法將80例非酒精性脂肪性肝炎患者,按數字錶法隨機分為治療組(40例)及對照組(40例)。治療組在控製飲食、適噹運動基礎上給予雙環醇聯閤多烯燐脂酰膽堿治療;對照組在控製飲食、適噹運動基礎上給予熊去氧膽痠治療。全部病例均連續治療12週。結果治療組總有效率為85.0%(34/40),對照組為55.0%(22/40),兩組差異有統計學意義(x2=8.5,P<0.01)。治療後,治療組ALT、AST、TG、TC與對照組相比,差異有統計學意義(t=2.13、3.36、5.00、4.45,P<0.05)。結論應用雙環醇聯閤多烯燐脂酰膽堿治療非酒精性脂肪性肝炎有效,值得臨床應用。
관찰쌍배순연합다희린지선담감치료비주정성지방성간염적료효。방법장80례비주정성지방성간염환자,안수자표법수궤분위치료조(40례)급대조조(40례)。치료조재공제음식、괄당운동기출상급여쌍배순연합다희린지선담감치료;대조조재공제음식、괄당운동기출상급여웅거양담산치료。전부병례균련속치료12주。결과치료조총유효솔위85.0%(34/40),대조조위55.0%(22/40),량조차이유통계학의의(x2=8.5,P<0.01)。치료후,치료조ALT、AST、TG、TC여대조조상비,차이유통계학의의(t=2.13、3.36、5.00、4.45,P<0.05)。결론응용쌍배순연합다희린지선담감치료비주정성지방성간염유효,치득림상응용。
Objective To observe the effects of bicyclol combined with polyunsaturated phosphatidylcholine in the treatment of non-alcoholic fatty hepatitis. Methods 80 patients with non-alcoholic steatohepatitis patients were randomly divided into treatment group (40 cases) and control group (40 cases). On the basis of diet control and adequate exercise, the treatment group was given united bicyclol polyene phosphatidylcholine and the control group was given ursodeoxycholic acid. All the patients were treated for 12 weeks. Results The total effective rate in treatment group was 85.0%(34/40), the rate was 55.0% (22/40)in control group, and there was statistical difference between the two groups( x2 = 8.5, P < 0.01 ). In treatment group, ALT, AST, TG, TC decreased significantly compared to those in control group(t=2.13, 3.36, 5.00, 4.45, P<0.05).Conclusions Bicyclol combiined with polyunsaturated phosphatidylcholine for nonalcoholic steatohepatitis therapy is effective and worthy for clinical application.